Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-16.40%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-16.40%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-247.92%
Never
—
—
Never
—
5 Years
Score—
Net Growth-247.92%
Net TrendNever
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Dyne Therapeutics Inc fundamental performance
Across Dyne Therapeutics Inc's full reported history, from 2020 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 58M to -$ 446M. Revenue increased in 0% of the years measured; net income in 0%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 26.17 | — |
1 Year2025-08-12 | $ 11.62 | 125.22% |
5 Years2021-08-12 | $ 17.33 | 51.01% |
All Time2020-09-17 | $ 23.90 | 9.50% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-09-17 |
|---|---|---|---|---|
| Price | $ 26.17 | $ 11.62 | $ 17.33 | $ 23.90 |
| Return | — | 125.22% | 51.01% | 9.50% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 519M | $ 898M |
| 2025 | $ 0.00 | -$ 446M | $ 1.11B |
| 2024 | $ 0.00 | -$ 317M | $ 642M |
| 2023 | $ 0.00 | -$ 235M | $ 123M |
| 2022 | $ 0.00 | -$ 165M | $ 256M |
| 2021 | $ 0.00 | -$ 149M | $ 376M |
| IPO2020 | $ 0.00 | -$ 58M | $ 345M |
Explore beyond DYN
You're looking at Dyne Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
